|
||||||
Executive Summary Summary Harvard University (Harvard) is an educational and research university that offers undergraduate and post graduate programs. The university offers courses such as accounting and management, anthropology, epidemiology, mathematics, music, pathology, psychology, sociology, visual and environmental studies, women's studies in religion, physics. It provides courses such as pediatric dentistry; landscape, architecture, and urban planning; biological chemistry and molecular pharmacology; comparative literature and microbiology and molecular genetics. Harvard offers libraries, museums, laboratories and research centers to support scholarly work. The university collaborates with other universities and research institutions for its research activities. It operates through various schools and colleges. Harvard is headquartered in Cambridge, Massachusetts, the US. Harvard University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector. Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios. Business Description-A brief description of the company's operations. Key Employees-A list of the key executives of the company. Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors-A list of the key competitors of the company. Key Recent Developments-A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Read More Contact Us:
Table of Contents Table of Contents List of Tables List of Figures Harvard University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 Harvard University, Medical Devices Deals, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deal Details Partnerships Frequency Therapeutics Enters into Agreement with Harvard University and US Army Institute of Surgical Research Les Laboratoires Servier Enters into Agreement with Harvard University Vir Biotechnology and Harvard University Enter into Research Agreement Elysium Health Enters into Research Agreement with Harvard University Thrive Bioscience and Harvard Stem Cell Institute Enter into Agreement Boehringer Ingelheim Enters into Research Agreement with Harvard Stem Cell Institute ConSynance Therapeutics Enters into Research Agreement with Harvard Medical School Medgenics Enters into Agreement with Harvard University Ipsen Enters into Research Agreement with Harvard University AstraZeneca Enters into Research Agreement with Harvard Stem Cell Institute Imcare Biotech Enters into Partnership with Harvard Medical School Astellas Pharma Enters into Research Agreement with Harvard Medical School Genocea Biosciences Enters Into Research Agreement With Dana-Farber Cancer Institute And Harvard Medical School Evotec Enters Into Research Agreement With Harvard University For Enteroendocrine Mechanisms Evotec Enters Into Research Agreement With Harvard Stem Cell Institute For Amyotrophic Lateral Sclerosis Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology Ipsen Enters Into Research Agreement With Harvard Medical School To Discover Botulinum Toxins Evotec Enters Into Research Agreement With Harvard University To Develop Antibacterial Drugs Emory University And Children's Hospital of Philadelphia Enter Into Co-Development Agreement With Harvard University UCB Enters Into R&D Agreement With Harvard University To Develop Immunology Drugs Pfizer Enters Into Co-Development Agreement With Harvard University UCB Enters Into Co-Development Agreement With Harvard University Evotec Enters Into Co-Development Agreement With Harvard University And BWH Licensing Agreements Mustang Bio Enters into Licensing Agreement with Harvard University X-Biotix Therapeutics Enters into Licensing Agreement with Harvard Medical School Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa Nobilis Therapeutics Enters into Licensing Agreement with Harvard University Merck Enters into Licensing Agreement with Harvard University Frequency Therapeutics Receives Intellectual Property Rights from MIT and Harvard Medical School Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology Columbia Labs Enters into Licensing Agreement for IVR Technology H&P Labs Enters into Licensing Agreement with Harvard University and Brigham and Women's Hospital Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology Mesoblast Enters into Licensing Agreement with Harvard Medical School Semma Therapeutics Enters into Licensing Agreement with Harvard University Allied-Bristol Life Sciences Enters into Licensing Agreement with Harvard University Macrolide Pharma Enters into Licensing Agreement with Harvard University Office of Technology Development Horizon Discovery Enters Into Licensing Agreement With Harvard University For Crispr Gene Editing Technology GNS Healthcare Enters Into Licensing Agreement With Harvard Medical School TissueNetix Enters Into Licensing Agreement With Harvard University For Muscular Thin Film Technology Evotec And Harvard University Enter Into Licensing Agreement With Janssen Pharma For Beta-Cell Regeneration Candidates SciFluor Life Sciences Extends Licensing Agreement With Harvard University For PET Imaging Insero Health Enters Into Patent Licensing Agreement With Harvard University Harvard University-Key Competitors Harvard University-Key Employees Harvard University-Locations And Subsidiaries Head Office Other Locations & Subsidiaries Recent Developments Government and Public Interest Mar 05, 2018: Personal cancer vaccines get their own boost Dec 27, 2017: Technical University of Munich: Double strike against tuberculosis Dec 20, 2017: CRISPR therapy preserves hearing in progressive deafness model Nov 16, 2017: Study shows codeine prescribed to children despite FDA warning against it Feb 10, 2017: U.S. Scientists Receive Inaugural $87 Million Grand Challenge Awards To Accelerate Global Progress To Beat Cancer Sooner Product News Nov 29, 2017: Innovative Microscope Poised to Propel Optogenetics Studies Appendix Methodology About GlobalData Contact Us Disclaimer List of Figures Harvard University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 Harvard University, Medical Devices Deals, 2012 to YTD 2018 List of Tables Harvard University, Pharmaceuticals & Healthcare, Key Facts Harvard University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Harvard University, Deals By Therapy Area, 2012 to YTD 2018 Harvard University, Medical Devices Deals, 2012 to YTD 2018 Harvard University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 Frequency Therapeutics Enters into Agreement with Harvard University and US Army Institute of Surgical Research Les Laboratoires Servier Enters into Agreement with Harvard University Vir Biotechnology and Harvard University Enter into Research Agreement Elysium Health Enters into Research Agreement with Harvard University Thrive Bioscience and Harvard Stem Cell Institute Enter into Agreement Boehringer Ingelheim Enters into Research Agreement with Harvard Stem Cell Institute ConSynance Therapeutics Enters into Research Agreement with Harvard Medical School Medgenics Enters into Agreement with Harvard University Ipsen Enters into Research Agreement with Harvard University AstraZeneca Enters into Research Agreement with Harvard Stem Cell Institute Imcare Biotech Enters into Partnership with Harvard Medical School Astellas Pharma Enters into Research Agreement with Harvard Medical School Genocea Biosciences Enters Into Research Agreement With Dana-Farber Cancer Institute And Harvard Medical School Evotec Enters Into Research Agreement With Harvard University For Enteroendocrine Mechanisms Evotec Enters Into Research Agreement With Harvard Stem Cell Institute For Amyotrophic Lateral Sclerosis Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology Ipsen Enters Into Research Agreement With Harvard Medical School To Discover Botulinum Toxins Evotec Enters Into Research Agreement With Harvard University To Develop Antibacterial Drugs Emory University And Children's Hospital of Philadelphia Enter Into Co-Development Agreement With Harvard University UCB Enters Into R&D Agreement With Harvard University To Develop Immunology Drugs Pfizer Enters Into Co-Development Agreement With Harvard University UCB Enters Into Co-Development Agreement With Harvard University Evotec Enters Into Co-Development Agreement With Harvard University And BWH Mustang Bio Enters into Licensing Agreement with Harvard University X-Biotix Therapeutics Enters into Licensing Agreement with Harvard Medical School Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa Nobilis Therapeutics Enters into Licensing Agreement with Harvard University Merck Enters into Licensing Agreement with Harvard University Frequency Therapeutics Receives Intellectual Property Rights from MIT and Harvard Medical School Juniper Pharma Enters into Licensing Agreement with Harvard Medical, Massachusetts General Hospital and Massachusetts Institute of Technology Columbia Labs Enters into Licensing Agreement for IVR Technology H&P Labs Enters into Licensing Agreement with Harvard University and Brigham and Women's Hospital Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology Mesoblast Enters into Licensing Agreement with Harvard Medical School Semma Therapeutics Enters into Licensing Agreement with Harvard University Allied-Bristol Life Sciences Enters into Licensing Agreement with Harvard University Macrolide Pharma Enters into Licensing Agreement with Harvard University Office of Technology Development Horizon Discovery Enters Into Licensing Agreement With Harvard University For Crispr Gene Editing Technology GNS Healthcare Enters Into Licensing Agreement With Harvard Medical School TissueNetix Enters Into Licensing Agreement With Harvard University For Muscular Thin Film Technology Evotec And Harvard University Enter Into Licensing Agreement With Janssen Pharma For Beta-Cell Regeneration Candidates SciFluor Life Sciences Extends Licensing Agreement With Harvard University For PET Imaging Insero Health Enters Into Patent Licensing Agreement With Harvard University Harvard University, Key Competitors Harvard University, Key Employees Harvard University, Other Locations Harvard University, Subsidiaries Single User License: Site License: Corporate User License: |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center" |